M&A

Sanofi to Buy Biogen Hemophilia Spinoff for $11.6 Billion
Bloomberg
Mon, 01/22/18 - 11:05 am
Sanofi
M&A
Bioverativ
Biogen
hemophilia
Idera, Biocryst to merge, rebrand and focus in rare disease programs
Endpoints
Mon, 01/22/18 - 10:56 am
Idera
Biocryst
M&A
Rare Diseases
Whom Will Pfizer Buy in 2018?
Motley Fool
Mon, 01/22/18 - 09:42 am
Pfizer
M&A
Biogen
Bristol-Myers Squibb
Allergan
Sanofi near deal to buy Bioverativ for more than $11.5 bln -WSJ
Yahoo/Reuters
Sun, 01/21/18 - 09:07 pm
Sanofi
M&A
Bioverativ
Consortium of Chinese companies tries to acquire J&J’s LifeScan and Calibra Medical ($3-4bn)
GoinPharma
Sun, 01/21/18 - 10:43 am
China
JNJ
LifeScan
Calibra
M&A
Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report
Endpoints
Fri, 01/19/18 - 11:15 am
Biogen
UCB Pharma
Acorda Therapeutics
M&A
Will This Tiny Biotech Be Celgene's Next Takeover Target?
Motley Fool
Fri, 01/19/18 - 11:07 am
Celgene
M&A
Jounce Therapeutics
Report: Small deals aren't the answer to big pharma's woes
Biopharma Dive
Fri, 01/19/18 - 10:07 am
M&A
Is Juno worth a $10B-$12B buyout price? Analysts see megabucks deal in the making on reported Celgene talks
Endpoints
Wed, 01/17/18 - 10:09 pm
Juno Therapeutics
Celgene
M&A
Celgene is reportedly in talks to buy Juno Therapeutics
CNBC
Wed, 01/17/18 - 11:40 am
Celgene
Juno Therapeutics
M&A
CAR-T
Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant -- Update
Morningstar
Wed, 01/17/18 - 11:27 am
Allergan
shareholders
Valeant Pharmaceuticals
M&A
GlaxoSmithKline eyes $1.7B bid for respiratory partner Vectura: report
Fierce Pharma
Tue, 01/16/18 - 07:00 pm
GSK
Vectura
respiratory disease
M&A
Saving America's Hospitals: Why Recent Mega Mergers Will Fail
Forbes
Tue, 01/16/18 - 09:52 am
hospitals
M&A
That Biotech M&A Wave? More like a Trickle
Barron's
Sun, 01/14/18 - 09:42 am
biotech
M&A
GSK seeks to protect Advair through GBP1.2bn acquisition of Vectura
GoinPharma
Sat, 01/13/18 - 01:59 pm
GSK
Advair
Vectura
M&A
Eli Lilly, sporting a lower tax rate, scouts smaller deals in immunology, cancer
Fierce Pharma
Thu, 01/11/18 - 11:56 pm
Eli Lilly
M&A
immunology
Charles River buys KWS BioTest for $20M, gaining immunology discovery capacity and a UK footprint
Endpoints
Thu, 01/11/18 - 09:53 am
Charles River Laboratories
KWS BioTest
M&A
immunology
R&D
J&J chief Gorksy bullish on tax reform, plans $16B in repatriated overseas cash
Mass Device
Wed, 01/10/18 - 11:38 am
tax reform
JNJ
Pharma CEOs
Alex Gorsky
M&A
5 Things Amgen's CEO Just Said That Investors Need to Know
Motley Fool
Wed, 01/10/18 - 10:13 am
Amgen
Pharma CEOs
Bob Bradway
Prolia
M&A
5 Ways Gilead Sciences Plans to Return to Growth
Motley Fool
Tue, 01/9/18 - 10:55 pm
Gilead Sciences
HIV
liver disease
cell therapy
inflammation
M&A

Pages